Reviews Leustatin


No reviews yet.

Leustatin Drug Description
Leustatin®
(cladribine) Injection
For Intravenous Infusion Only

WARNING
LEUSTATIN (cladribine) Injection should be administered under the supervision of a qualified physician experienced in the use of antineoplastic therapy. Suppression of bone marrow function should be anticipated. This is usually reversible and appears to be dose dependent. Serious neurological toxicity (including irreversible paraparesis and quadraparesis) has been reported in patients who received LEUSTATIN Injection by continuous infusion at high doses (4 to 9 times the recommended dose for Hairy Cell Leukemia). Neurologic toxicity appears to demonstrate a dose relationship; however, severe neurological toxicity has been reported rarely following treatment with standard cladribine dosing regimens.
Acute nephrotoxicity has been observed with high doses of LEUSTATIN (4 to 9 times the recommended dose for Hairy Cell Leukemia), especially when given concomitantly with other nephrotoxic agents/therapies.

DRUG DESCRIPTION



What are the possible side effects of cladribine (Cladribine Novaplus, Leustatin)?

If you experience any of the following serious side effects, seek emergency medical attention or contact your doctor immediately:

an allergic reaction (shortness of breath; closing of your throat; difficulty breathing; swelling of your lips, face, or tongue; or hives);
decreased bone marrow function and blood problems (extreme fatigue; unusual bruising or bleeding; black, bloody or tarry stools; or fever, chills, sore throat, or signs of infection);
...
Read All Potential Side Effects for Leustatin »




LEUSTATIN (cladribine) Injection (also commonly known as 2-chloro-2 -deoxy-
β -D-adenosine) is a synthetic antineoplastic agent for continuous intravenous
infusion. It is a clear, colorless, sterile, preservative-free, isotonic solution.
LEUSTATIN Injection is available in single-use vials containing 10 mg (1 mg/mL)
of cladribine, a chlorinated purine nucleoside analog. Each milliliter of LEUSTATIN
Injection contains 1 mg of the active ingredient and 9 mg (0.15 mEq) of sodium
chloride as an inactive ingredient. The solution has a pH range of 5.5 to 8.0.
Phosphoric acid and/or dibasic sodium phosphate may have been added to adjust
the pH to 6.3±0.3.
The chemical name for cladribine is 2-chloro-6-amino-9-(2-deoxy-β-D-erythropento-furanosyl) purine and the structure is represented below:







cladribine...............MW 285.7Last reviewed on RxList: 10/23/2008




Leustatin Drug Description
Leustatin®
(cladribine) Injection
For Intravenous Infusion Only

WARNING
LEUSTATIN (cladribine) Injection should be administered under the supervision of a qualified physician experienced in the use of antineoplastic therapy. Suppression of bone marrow function should be anticipated. This is usually reversible and appears to be dose dependent. Serious neurological toxicity (including irreversible paraparesis and quadraparesis) has been reported in patients who received LEUSTATIN Injection by continuous infusion at high doses (4 to 9 times the recommended dose for Hairy Cell Leukemia). Neurologic toxicity appears to demonstrate a dose relationship; however, severe neurological toxicity has been reported rarely following treatment with standard cladribine dosing regimens.
Acute nephrotoxicity has been observed with high doses of LEUSTATIN (4 to 9 times the recommended dose for Hairy Cell Leukemia), especially when given concomitantly with other nephrotoxic agents/therapies.

DRUG DESCRIPTION



What are the possible side effects of cladribine (Cladribine Novaplus, Leustatin)?

If you experience any of the following serious side effects, seek emergency medical attention or contact your doctor immediately:

an allergic reaction (shortness of breath; closing of your throat; difficulty breathing; swelling of your lips, face, or tongue; or hives);
decreased bone marrow function and blood problems (extreme fatigue; unusual bruising or bleeding; black, bloody or tarry stools; or fever, chills, sore throat, or signs of infection);
...
Read All Potential Side Effects for Leustatin »




LEUSTATIN (cladribine) Injection (also commonly known as 2-chloro-2 -deoxy-
β -D-adenosine) is a synthetic antineoplastic agent for continuous intravenous
infusion. It is a clear, colorless, sterile, preservative-free, isotonic solution.
LEUSTATIN Injection is available in single-use vials containing 10 mg (1 mg/mL)
of cladribine, a chlorinated purine nucleoside analog. Each milliliter of LEUSTATIN
Injection contains 1 mg of the active ingredient and 9 mg (0.15 mEq) of sodium
chloride as an inactive ingredient. The solution has a pH range of 5.5 to 8.0.
Phosphoric acid and/or dibasic sodium phosphate may have been added to adjust
the pH to 6.3±0.3.
The chemical name for cladribine is 2-chloro-6-amino-9-(2-deoxy-β-D-erythropento-furanosyl) purine and the structure is represented below:







cladribine...............MW 285.7Last reviewed on RxList: 10/23/2008




Leustatin Drug Description
Leustatin®
(cladribine) Injection
For Intravenous Infusion Only

WARNING
LEUSTATIN (cladribine) Injection should be administered under the supervision of a qualified physician experienced in the use of antineoplastic therapy. Suppression of bone marrow function should be anticipated. This is usually reversible and appears to be dose dependent. Serious neurological toxicity (including irreversible paraparesis and quadraparesis) has been reported in patients who received LEUSTATIN Injection by continuous infusion at high doses (4 to 9 times the recommended dose for Hairy Cell Leukemia). Neurologic toxicity appears to demonstrate a dose relationship; however, severe neurological toxicity has been reported rarely following treatment with standard cladribine dosing regimens.
Acute nephrotoxicity has been observed with high doses of LEUSTATIN (4 to 9 times the recommended dose for Hairy Cell Leukemia), especially when given concomitantly with other nephrotoxic agents/therapies.

DRUG DESCRIPTION



What are the possible side effects of cladribine (Cladribine Novaplus, Leustatin)?

If you experience any of the following serious side effects, seek emergency medical attention or contact your doctor immediately:

an allergic reaction (shortness of breath; closing of your throat; difficulty breathing; swelling of your lips, face, or tongue; or hives);
decreased bone marrow function and blood problems (extreme fatigue; unusual bruising or bleeding; black, bloody or tarry stools; or fever, chills, sore throat, or signs of infection);
...
Read All Potential Side Effects for Leustatin »




LEUSTATIN (cladribine) Injection (also commonly known as 2-chloro-2 -deoxy-
β -D-adenosine) is a synthetic antineoplastic agent for continuous intravenous
infusion. It is a clear, colorless, sterile, preservative-free, isotonic solution.
LEUSTATIN Injection is available in single-use vials containing 10 mg (1 mg/mL)
of cladribine, a chlorinated purine nucleoside analog. Each milliliter of LEUSTATIN
Injection contains 1 mg of the active ingredient and 9 mg (0.15 mEq) of sodium
chloride as an inactive ingredient. The solution has a pH range of 5.5 to 8.0.
Phosphoric acid and/or dibasic sodium phosphate may have been added to adjust
the pH to 6.3±0.3.
The chemical name for cladribine is 2-chloro-6-amino-9-(2-deoxy-β-D-erythropento-furanosyl) purine and the structure is represented below:







cladribine...............MW 285.7Last reviewed on RxList: 10/23/2008




Leustatin Drug Description
Leustatin®
(cladribine) Injection
For Intravenous Infusion Only

WARNING
LEUSTATIN (cladribine) Injection should be administered under the supervision of a qualified physician experienced in the use of antineoplastic therapy. Suppression of bone marrow function should be anticipated. This is usually reversible and appears to be dose dependent. Serious neurological toxicity (including irreversible paraparesis and quadraparesis) has been reported in patients who received LEUSTATIN Injection by continuous infusion at high doses (4 to 9 times the recommended dose for Hairy Cell Leukemia). Neurologic toxicity appears to demonstrate a dose relationship; however, severe neurological toxicity has been reported rarely following treatment with standard cladribine dosing regimens.
Acute nephrotoxicity has been observed with high doses of LEUSTATIN (4 to 9 times the recommended dose for Hairy Cell Leukemia), especially when given concomitantly with other nephrotoxic agents/therapies.

DRUG DESCRIPTION



What are the possible side effects of cladribine (Cladribine Novaplus, Leustatin)?

If you experience any of the following serious side effects, seek emergency medical attention or contact your doctor immediately:

an allergic reaction (shortness of breath; closing of your throat; difficulty breathing; swelling of your lips, face, or tongue; or hives);
decreased bone marrow function and blood problems (extreme fatigue; unusual bruising or bleeding; black, bloody or tarry stools; or fever, chills, sore throat, or signs of infection);
...
Read All Potential Side Effects for Leustatin »




LEUSTATIN (cladribine) Injection (also commonly known as 2-chloro-2 -deoxy-
β -D-adenosine) is a synthetic antineoplastic agent for continuous intravenous
infusion. It is a clear, colorless, sterile, preservative-free, isotonic solution.
LEUSTATIN Injection is available in single-use vials containing 10 mg (1 mg/mL)
of cladribine, a chlorinated purine nucleoside analog. Each milliliter of LEUSTATIN
Injection contains 1 mg of the active ingredient and 9 mg (0.15 mEq) of sodium
chloride as an inactive ingredient. The solution has a pH range of 5.5 to 8.0.
Phosphoric acid and/or dibasic sodium phosphate may have been added to adjust
the pH to 6.3±0.3.
The chemical name for cladribine is 2-chloro-6-amino-9-(2-deoxy-β-D-erythropento-furanosyl) purine and the structure is represented below:







cladribine...............MW 285.7Last reviewed on RxList: 10/23/2008




Leustatin Drug Description
Leustatin®
(cladribine) Injection
For Intravenous Infusion Only

WARNING
LEUSTATIN (cladribine) Injection should be administered under the supervision of a qualified physician experienced in the use of antineoplastic therapy. Suppression of bone marrow function should be anticipated. This is usually reversible and appears to be dose dependent. Serious neurological toxicity (including irreversible paraparesis and quadraparesis) has been reported in patients who received LEUSTATIN Injection by continuous infusion at high doses (4 to 9 times the recommended dose for Hairy Cell Leukemia). Neurologic toxicity appears to demonstrate a dose relationship; however, severe neurological toxicity has been reported rarely following treatment with standard cladribine dosing regimens.
Acute nephrotoxicity has been observed with high doses of LEUSTATIN (4 to 9 times the recommended dose for Hairy Cell Leukemia), especially when given concomitantly with other nephrotoxic agents/therapies.

DRUG DESCRIPTION



What are the possible side effects of cladribine (Cladribine Novaplus, Leustatin)?

If you experience any of the following serious side effects, seek emergency medical attention or contact your doctor immediately:

an allergic reaction (shortness of breath; closing of your throat; difficulty breathing; swelling of your lips, face, or tongue; or hives);
decreased bone marrow function and blood problems (extreme fatigue; unusual bruising or bleeding; black, bloody or tarry stools; or fever, chills, sore throat, or signs of infection);
...
Read All Potential Side Effects for Leustatin »




LEUSTATIN (cladribine) Injection (also commonly known as 2-chloro-2 -deoxy-
β -D-adenosine) is a synthetic antineoplastic agent for continuous intravenous
infusion. It is a clear, colorless, sterile, preservative-free, isotonic solution.
LEUSTATIN Injection is available in single-use vials containing 10 mg (1 mg/mL)
of cladribine, a chlorinated purine nucleoside analog. Each milliliter of LEUSTATIN
Injection contains 1 mg of the active ingredient and 9 mg (0.15 mEq) of sodium
chloride as an inactive ingredient. The solution has a pH range of 5.5 to 8.0.
Phosphoric acid and/or dibasic sodium phosphate may have been added to adjust
the pH to 6.3±0.3.
The chemical name for cladribine is 2-chloro-6-amino-9-(2-deoxy-β-D-erythropento-furanosyl) purine and the structure is represented below:







cladribine...............MW 285.7Last reviewed on RxList: 10/23/2008





Other reviews about Leustatin on wordpress

Cladribine Reduces Relapse Rates in Relapsing-Remitting MS
  by macacinha
Full results of the Cladribine Tablets Treating MS Orally (CLARITY) trial of oral cladribine (Leustatin, Ortho Biotech) in patients with relapsing-remitting multiple sclerosis (MS) […]


Americans Need Help Getting Meds- How to Get Free or Reduced Needed RX medications
  by paganmedia
Thanks to USA federal government incentives, pharmaceutical companies may provide free prescription medicines if : Sourced and Submitted: By Lady Paradise ~ With much appreciated thanks on this […]


ReportsandReports – World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition, The
  by reportsnreports
Browse the complete Report on: World Market for Cancer Therapeutics and Biotherapeutics, 3rd. Edition, The Browse All Kalorama Information Reports at Kalorama Information Worldwide cancer affects more than 10 million […]



Other reviews about Leustatin on web:

Learn about the prescription medication Leustatin (Cladribine), drug uses, dosage, side effects, drug interactions, warnings, reviews and patient labeling. Leustatin (Cladribine) Drug Information: Uses, Side Effects, Drug ...


Accurate, FDA approved Leustatin information for healthcare professionals and patients - brought to you by Drugs.com. Leustatin Official FDA information, side effects and uses.


Cladribine (Leustatin) is a drug used to treat hairy cell leukemia (leukemic reticuloendotheliosis) and multiple sclerosis. Its chemical name is 2-chlorodeoxyadenosine (2CDA). Cladribine - Wikipedia, the free encyclopedia


All about Leustatin. View complete and up to date Leustatin information - part of the Drugs.com trusted medication database. Leustatin Facts and Comparisons at Drugs.com


Leustatin is the trade name for Cladribine. 2-CdA and 2-Chlorodeoxyadenosine are other names for Cladribine. Leustatin is an anti-cancer chemotherapy drug. This medication is ... Leustatin, Cladribine, 2-CdA - Chemotherapy Drugs, Chemo Drug Side ...


Find patient medical information for Leustatin IV on WebMD including its uses, side effects and safety, interactions, pictures, warnings and user ratings. Leustatin IV : Uses, Side Effects, Interactions, Pictures ...


What is Leustatin (Cladribine)? Cladribine is a cancer medication that interferes with the growth of cancer cells and slows their growth and spread in the body. Leustatin - Drugs & Treatments - Revolution Health


News on Leustatin, Cladribine (generic) continually updated from thousands of sources around the net. Leustatin, Cladribine News - Topix


Leustatin - Cladribine is a cancer medication that interferes with the growth of cancer cells and slows their growth and spread in the body. - Do not use cladribine if you are ... Leustatin - Side Effects, Dosage, Interactions - Drugs ...


11/16/2007 8/23/2007 1 LEUSTATIN ® (cladribine) Injection For Intravenous Infusion Only WARNING LEUSTATIN (cladribine) Injection should be administered under the supervision of a qualified ... LEUSTATIN® (cladribine) Injection For Intravenous Infusion Only





Featured Reviews

Reviews Lutera

Lutera Drug Description Lutera™ (Levonorgestrel and Ethinyl Estradiol Tablets USP) Rx only Patients should be counseled that this product does not protect against HIV infection (AIDS) and other sexually transmitted diseases....
Read More  |  Review This
Reviews Rizatriptan Benzoate

Maxalt Drug Description MAXALT® (Rizatriptan benzoate) Tablets MAXALT-MLT® (Rizatriptan benzoate) Orally Disintegrating Tablets DRUG DESCRIPTION What are the possible side effects of rizatriptan (Maxalt, Maxalt-MLT)? Get...
Read More  |  Review This
Reviews Metozolv ODT

Metozolv ODT Drug Description METOZOLV ODT (metoclopramide hydrochloride) Orally Disintegrating Tablets WARNING: TARDIVE DYSKINESIA Treatment with metoclopramide can cause tardive dyskinesia, a serious movement disorder that is often...
Read More  |  Review This
Reviews Cognex

Cognex Drug Description Cognex® (tacrine hydrochloride) Capsules, USP DRUG DESCRIPTION What are the possible side effects of tacrine (Cognex)? Get emergency medical help if you have any of these signs of an allergic reaction:...
Read More  |  Review This
Reviews Timolol Maleate Ophthalmic Gel Forming Solution

Timoptic-XE Drug Description TIMOPTIC-XE® 0.25% AND 0.5% (timolol maleate) Ophthalmic Gel Forming Solution DRUG DESCRIPTION What are the possible side effects of timolol ophthalmic? Get emergency medical help if you have...
Read More  |  Review This
Recent News
59sec - the BEST lead management system around!
We tested 59sec - THE lead management system and we love it. 59sec helps small and medium companies to answer leads in maximum 59 seconds. Why...
MOVEorPAY - our favorite facebook app
We do love MOVEorPAY motivational facebook app, because it is very cool and useful. It makes you finish stuff that you know are good for you, but from various reasons, you never do...
ReviewsAZ is almost ready to be officially launched
yes, we have just a few loose ends to tie and we are ready to go :) meanwhile, I am putting some reviews on the site, so people will not get an empty site at the launch....